USPTO serial 79358950
QUOUR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 29, 2025
- Examiner
- RILEY, KATHERINE M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with QUOUR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparations and articles, namely, medical preparations for the treatment of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, endometriosis, asthma allergy, cancer, autoimmune diseases, neurological diseases and infectious diseases; diagnostic preparations and materials, namely, diagnostic preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; pharmaceuticals in the nature of pharmaceutical preparations for the treatment and prevention of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, endometriosis, asthma, allergy, autoimmune diseases and infectious diseases and natural remedies in the nature of natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; homeopathic medicines and pharmaceuticals, namely, homeopathic pharmaceuticals for use in the treatment of cardiac arrhythmias, hypertension, pneumonia, diabetes, obesity and metabolism, asthma, allergy, autoimmune diseases and infectious diseases; biotechnological preparations for medical use in the nature of pharmaceutical preparations for the treatment and prevention of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, endometriosis, asthma and allergy; biotechnological pharmaceutical preparations for gene and cell therapy, all being for medical purposes; Colostral antibodies for medical purposes; sanitary preparations and articles, namely, sanitary preparations for medical use; vaccines; reagents for medical use; medical dressings, plasters and applicators in the nature of swabs for medical purposes, wound dressings, adhesive plasters for wound care, cotton sticks for medical purposes and pre-filled syringes with pharmaceutical preparations, namely, pre-filled syringes filled with insulin for medical purposes | ACTIVE | — |
| 009 | Sensors, detectors and monitoring instruments, namely, alarm sensors, timing sensors, motion sensors, smoke detectors, radar detectors, temperature sensors; Downloadable medical software for providing and faciliting medical diagnosis, and for managing data and communications related to clinical trials, pharmaceutical, scientific, biological and clinical research for use in the fields of medicine, biothechnology, pharmacology, drug discovery and development; data and file management software and database software, namely downloadable computer software for providing database management in the field of providing medical diagnosis, clinical trials, pharmaceutical, scientific, biological and clinical research for use in the fields of medicine, biothechnology, pharmacology, drug discovery and development; data management software, namely, downloadable computer software for managing electronic data; Downloadable software for recording, analysis, evaluation and reporting of data | ACTIVE | — |
| 010 | Medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate; diagnostic, examination, and monitoring equipment, namely, medical devices for use in diagnosing of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, hypertension, endometriosis, asthma, endometriosis, renal impairment, hepatology, hemostaseology, cancer, autoimmune diseases, neurological diseases and infectious diseases; testing apparatus for medical purposes, namely, medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA; artificial limbs; injectors for medical purposes, namely, medical fluid injectors; inhalers for medical purposes, sold empty; medical instruments for use in treating cardiac arrhythmias and hypertension; measuring instruments adapted for medical use, namely, medical instruments for measuring blood pressure, lung capacity; medical apparatus used in the manufacture of drugs, medical products and medical apparatus, namely, medical apparatus for use in treating respiratory diseases, cardiovascular diseases, rheumatoid arthritis; prosthetics in the nature of prosthetic limbs, namely, arms, feet, legs and artificial implants in the nature of surgical implants comprised of artificial materials; surgical and wound treating equipment, namely, surgical instruments for use in orthopedic surgery, in general surgery; medical diagnostic apparatus and equipment, namely, medical diagnostic apparatus for testing the heart conditions, medical diagnostic apparatus for use in the fields of cancer, cell-based testing; clothing especially for operating rooms, orthodontic headgear and orthopedic footwear, medical braces for knee, ankle, elbow and supports for ankle, wrist, for medical purposes; physical therapy equipment, namely, physical therapy equipment in the nature of foam rollers, manually-operated resistance tubing, weighted balls; mobility aids, namely, walkers to aid mobility | ACTIVE | — |
| 034 | Articles for use with tobacco, namely, tobacco grinders; personal oral vaporizers for smoking purposes and electronic cigarettes, and flavourings and solutions therefor in the nature of chemical flavourings in liquid form used to refill electronic cigarette cartridges | ACTIVE | — |
| 035 | Business consultancy and advisory services; business consultancy services relating to the supply of quality management systems; compilation of statistics; business assistance, management and administrative services; business administration; business consultancy relating to the preparation, creation and submission of permit applications including the authorities and ethics committees | ACTIVE | — |
| 036 | Investment services, namely, private equity fund investment services, real estate investment services; business investment services, namely, hedge fund investment services; financial information, data analysis, advice and consultancy services, financial credit assessment and credit information in the nature of credit rating services, financial appraisal services in responding to calls for tenders, financial planning services, financing and funding services in the nature of venture capital funding services to emerging and start-up companies, venture capital services in the nature of venture capital financing; fundraising services by means of organizing, arranging and conducting fundraising programs for the benefit of youth sports programs, schools, non-profit organizations, and financial sponsorship of charitable events, cultural events, concerts, sporting events, festivals, and awards shows; valuation services, namely, financial valuations | ACTIVE | — |
| 041 | Provision of training and further training, namely, training services in the fields of biotechnology, medicine, pharmacology, pharmacy, pharmaceutics, drug development, clinical trials, drug regulatory affairs, clinical data management, drug safety, quality management of clinical trials, biostatistics, lab analytics and pre-clinical research, investigation of drug-drug and food-drug interactions; organizing and conducting seminars, webinars, workshops, congresses and conferences in the fields of biotechnology, medicine, pharmacology, investigation of drug-drug and food-drug interactions; conducting of online seminars in the fields of biotechnology, medicine, pharmacology, pharmacy, pharmaceutics, drug development, clinical trials, drug regulatory affairs, clinical data management, drug safety, quality management of clinical trials, biostatistics, lab analytics and pre-clinical research investigation of drug-drug and food-drug interactions; publication of scientific research papers, books, magazines in the field of printed matters and digital media relating to clinical trials, drug development, biotechnology, medicine, pharmacology, pharmacy, pharmaceutics, drug regulatory affairs, clinical data management, drug safety, quality management of clinical trials, biostatistics, lab analytics and pre-clinical research, investigation of drug-drug and food-drug interactions | ACTIVE | — |
| 042 | Medical and pharmacological research services; research and development in the field of biotechnology; Medical laboratory services; research laboratories, namely, laboratory research in the fields of bacteriology, biotechnology; analytical medical laboratory services; clinical research in the field of pharmacology; information agency services, namely, providing medical and scientific research information in the field of clinical trials; provision of information relating to scientific research in the fields of cardiology, dermatology, the prevention, treatment and management of illness, hepatology, diabetes, obesity and metabolism, hypertension, hemostaseology, endometriosis, oncology, neurology, autoimmunology and infectiology; testing, authentication and quality control, namely, testing, analysis, and evaluation of small molecules, biotechnological products, medical devices and application systems and digital health solutions to assure compliance with pharmaceutical and medical safety, quality and regulatory industry standards; pharmaceutical drug and medicine development; consultancy relating to biotechnology; Pharmaceutical research services in the nature of searching, identifying and assessing candidate pharmaceutical substances; quality control monitoring and auditing in the nature of monitoring small molecules, biotechnological products, medical devices and application systems and digital health solutions for quality control purposes; preparation of scientific reports in the nature of providing scientific information in the fields of biotechnology, clinical pharmacology, drug discovery, drug development; software as a service (SaaS) services featuring software for use in clinical database management, and rental of computer software for processing, diagnosing and analyzing medical data; product development | ACTIVE | — |
| 044 | Medical services; pharmaceutical services, namely, pharmaceutical compounding services; animal healthcare services; information and counselling services in the field of medicine and preparation of prescriptions in pharmacies; advisory services relating to medical services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Apleonex AG
- Other trademarks owned by Apleonex AG
- Other trademarks owned by Apleonex AG
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 034
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named QUOUR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 14, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 13, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 29, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 29, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 29, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 15, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 15, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 18, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 18, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 18, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 9, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 9, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 8, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 10, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 19, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 18, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 30, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |